Attenuated serum vasoactive intestinal peptide concentrations are correlated with disease severity of non-traumatic osteonecrosis of femoral head

被引:10
|
作者
Liu, Ming [1 ,2 ]
Zhao, Gan [1 ,3 ]
Wei, Biao-Fang [4 ]
机构
[1] Guangzhou Univ Chinese Med, Guangzhou, Guangdong, Peoples R China
[2] Linyi Peoples Hosp, Dept Pain, Linyi, Shandong, Peoples R China
[3] Linyi Tradit Chinese Med Hosp, Dept Sports Med, Linyi, Shandong, Peoples R China
[4] Linyi Peoples Hosp, Dept Orthoped, Jie Fang Rd East 27, Linyi 276003, Shandong, Peoples R China
关键词
Non-traumatic osteonecrosis of the femoral head; Disease severity; Vasoactive intestinal peptide; VIP; EXPRESSION;
D O I
10.1186/s13018-021-02486-3
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background and objectiveThe neuropeptide vasoactive intestinal peptide is a 28-amino acid neuropeptide that has been shown to stimulate bone repair and angiogenesis. The purpose of this study was to explore the potential role of serum VIP concentration in osteonecrosis of femoral trauma (ONFH).MethodsOne hundred five patients diagnosed with non-traumatic ONFH and 103 healthy individuals were enrolled in our study. Serum VIP, tumor necrosis factor-alpha (TNF-alpha), interluekin-1 beta (IL-1 beta), and macrophage colony-stimulating factor (M-CSF) levels also were detected using the commercial ELISA kit. Radiographic progression was evaluated using FICAT classification. The clinical severity of ONFH was assessed by visual analog score (VAS) and Harris Hip Score (HHS). Receiver-operating characteristic (ROC) curve was performed to test the potential diagnostic value of VIP in radiographic progression.ResultsThe serum VIP level of patients with non-traumatic ONFH was significantly lower than that of healthy controls. There was no significant difference between the alcohol group, the steroid-induction group, and the idiopathic group. Serum VIP levels were significantly higher in ONFH patients with femoral head pre-collapse stage than collapse stage. Serum VIP levels were significantly lower. FICAT 4 non-traumatic ONFH patients had significantly lower serum concentrations of VIP when compared with FICAT 3 and FICAT 2. Moreover, serum VIP levels were significantly lower in ONFH patients with FICAT 3 than FICAT 2. Serum VIP levels were negatively related to FICAT stage. In addition, serum VIP levels were negatively associated with VAS score and positively associated with HHS score. Last, we found serum VIP levels were negatively associated with serum TNF-alpha and IL-1 beta levels. ROC curve analysis indicated that decreased serum VIP could serve as a decent biomarker with regard to the diagnosis of radiographic progression.ConclusionAttenuated serum VIP concentrations are correlated with disease severity of non-traumatic ONFH. Decreased serum VIP may serve as a potential indicator of non-traumatic ONFH.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Attenuated serum vasoactive intestinal peptide concentrations are correlated with disease severity of non-traumatic osteonecrosis of femoral head
    Ming Liu
    Gan Zhao
    Biao-Fang Wei
    Journal of Orthopaedic Surgery and Research, 16
  • [2] Attenuated serum adiponectin levels are associated with disease severity in patients with non-traumatic osteonecrosis of the femoral head
    Yue, Yong-Bin
    Liu, Xin
    Wei, Biao-Fang
    JOURNAL OF PAIN RESEARCH, 2017, 10 : 2387 - 2393
  • [3] Decreased serum CXCL12/SDF-1 concentrations may reflect disease severity of non-traumatic osteonecrosis of femoral head
    Zheng, Shao-Wei
    Sun, Chun-Han
    Wen, Zhi-Jia
    Liu, Wei-Le
    Li, Xu
    Chen, Tian-Yu
    Zou, Yu-Cong
    Zhong, Hao-Bo
    Shi, Zhan-Jun
    CLINICA CHIMICA ACTA, 2022, 529 : 87 - 95
  • [4] Correlation of serum and local CXCL13 levels with disease severity in patients with non-traumatic osteonecrosis of femoral head
    Yong-Heng Zhao
    Wen-Xiu Zhu
    Qing-He Ye
    Peng Zhang
    Biao-Fang Wei
    Journal of Orthopaedic Surgery and Research, 19
  • [5] Correlation of serum and local CXCL13 levels with disease severity in patients with non-traumatic osteonecrosis of femoral head
    Zhao, Yong-Heng
    Zhu, Wen-Xiu
    Ye, Qing-He
    Zhang, Peng
    Wei, Biao-Fang
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2024, 19 (01)
  • [6] Serum nicotinamide phosphoribosyltransferase as a novel biomarker for non-traumatic osteonecrosis of the femoral head
    Shiying Wang
    Huixian Zhan
    Liping Xu
    Baoxiang Zhao
    Journal of Orthopaedic Surgery and Research, 17
  • [7] Serum metabolomic study for detecting biomarkers of non-traumatic osteonecrosis of the femoral head
    Xu, Zhongwei
    Xu, Kaimin
    Ding, Shijia
    Luo, Jiao
    Chen, Tingmei
    Zhou, Aiguo
    Wen, Zhenxing
    Zhang, Jian
    METABOLOMICS, 2017, 13 (06)
  • [8] Serum metabolomic study for detecting biomarkers of non-traumatic osteonecrosis of the femoral head
    Zhongwei Xu
    Kaimin Xu
    Shijia Ding
    Jiao Luo
    Tingmei Chen
    Aiguo Zhou
    Zhenxing Wen
    Jian Zhang
    Metabolomics, 2017, 13
  • [9] Serum nicotinamide phosphoribosyltransferase as a novel biomarker for non-traumatic osteonecrosis of the femoral head
    Wang, Shiying
    Zhan, Huixian
    Xu, Liping
    Zhao, Baoxiang
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2022, 17 (01)
  • [10] Reduced serum and local LncRNA MALAT1 expressions are linked with disease severity in patients with non-traumatic osteonecrosis of the femoral head
    Jin, Yan
    Zhu, Hong-Xun
    Wei, Biao-Fang
    TECHNOLOGY AND HEALTH CARE, 2021, 29 (03) : 479 - 488